Daniel Lindholm

Also affiliated with Uppsala University Hospital, Södertälje Sjukhus

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan”.

Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan

JACC Heart Failure(2020)10.1016/j.jchf.2020.04.008

N/A

5.0DataRank · unranked

142 citations

Pardeep S. Jhund, Brian Claggett, Pooja Dewan, Lars Køber, Mikhail Kosiborod +11 more

Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial

Circulation(2022)10.1161/circulationaha.122.061754

N/A

4.2DataRank · unranked

152 citations

Pardeep S. Jhund, Jan Bělohlávek, Rudolf A. de Boer, Chern‐En Chiang, Akshay S. Desai +22 more

Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JAMA Cardiology(2022)10.1001/jamacardio.2022.3750

N/A

2.9DataRank · unranked

67 citations

Brian Claggett, Pardeep S. Jhund, Rudolf A. de Boer, Adrian F. Hernandez, Silvio E. Inzucchi +12 more

Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial

Nature Medicine(2022)10.1038/s41591-022-02102-9

N/A

1.7DataRank · unranked

67 citations

James C. Fang, Akshay S. Desai, Pardeep S. Jhund, Brian Claggett, Muthiah Vaduganathan +19 more

Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA‐HF

European Journal of Heart Failure(2020)10.1002/ejhf.2083

N/A

1.7DataRank · unranked

48 citations

Kieran F. Docherty, Olof Bengtsson, Rudolf A. de Boer, Akshay S. Desai, Jarosław Dróżdż +19 more

Influence of NT-proBNP on Efficacy of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JACC Heart Failure(2022)10.1016/j.jchf.2022.08.007

N/A

1.5DataRank · unranked

50 citations

Muthiah Vaduganathan, Brian Claggett, Zi Michael Miao, Pardeep S. Jhund, Rudolf A. de Boer +13 more

Efficacy of Dapagliflozin in Black Versus White Patients With Heart Failure and Reduced Ejection Fraction

JACC Heart Failure(2021)10.1016/j.jchf.2021.08.006

N/A

0.900DataRank · unranked

49 citations

Modele O. Ogunniyi, Inder S. Anand, Akshay S. Desai, Mirta Díez, Jonathan G. Howlett +17 more

Impact of COVID-19 in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction Enrolled in the DELIVER Trial

European Journal of Heart Failure(2023)10.1002/ejhf.3043

N/A

0.691DataRank · unranked

16 citations

Mikhail Kosiborod, Brian Claggett, Zi Michael Miao, Muthiah Vaduganathan, Carolyn S.P. Lam +19 more

Effect of Dapagliflozin, Compared With Placebo, According to Baseline Risk in DAPA-HF

JACC Heart Failure(2022)10.1016/j.jchf.2021.09.002

N/A

0.614DataRank · unranked

13 citations

Joanne Simpson, Pardeep S. Jhund, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod +10 more